Article
Autophagy inhibition sensitizes radiotherapy responses in high-grade mutant IDH1 glioma.
Nature communications - 18 Sept 2026
Núñez Felipe J, Banerjee Kaushik, Mujeeb Anzar A, Mauser Ava, Tronrud Claire E, Zhu Ziwen, Raghuram Sadhakshi, Sheth Maya R, Pena Agudelo Jorge Armando, Zelaya Julio, Taher Ayman, Kadiyala Padma, Carney Stephen V, Garcia-Fabiani Maria B, Comba Andrea, Alghamri Mahmoud S, McClellan Brandon L, Klaiss Adam, Nwosu Zeribe C, Hong Hanna S, Sajjakulnukit Peter, Qin Tingting, Sartor Maureen A, Ljungman Mats, Welch Joshua D, Cheng Shi-Yuan, Lowenstein Pedro R, Lahann Joerg, Lyssiotis Costas A, Castro Maria G
Abstract excerpt
Mutant isocitrate dehydrogenase 1 (mIDH1) catalyzes 2-hydroxyglutarate (2HG) production which leads to epigenetic reprogramming in astrocytomas with tumor protein p53 (TP53)/α-thalassemia/mental retardation, X-linked (ATRX) loss. RNA-sequencing, single-cell RNA-sequencing, and Chromatin Immunoprecipitation sequencing (ChIP-seq) followed by bioinformatics analysis shows that human and mouse mIDH1 gliomas exhibit...
Read the complete abstract on PubMedTopics
- Humans
- Isocitrate Dehydrogenase
- Autophagy
